The interaction of integrin alpha (4)beta (1) with endothelial VCAM-1 contr
ols the trafficking of lymphocytes from blood into peripheral tissues. Cell
s actively regulate the affinity of alpha (4)beta (1) for VCAM-1 (activatio
n). To investigate the biological function of alpha (4)beta (1) activation,
we isolated Jurkat T cell lines with defective alpha (4)beta (1) activatio
n. Using these cells, we found that alpha (4)beta (1)-stimulated alpha (L)b
eta (2)-dependent cell migration was dramatically reduced in cells with def
ects in alpha (4)beta (1) activation. These cells required 20 times more VC
AM-1 to promote alpha (L)beta (2)-dependent cell migration. This defect was
at the level of alpha (4)beta (1) affinity as an activating alpha (4)beta
(1) Ab rescued alpha (4)beta (1)-stimulated alpha (L)beta (2)-dependent mig
ration. In contrast, migration of alpha (4)beta (1) activation-defective ce
lls on VCAM-1 alone was enhanced at higher VCAM-1 densities. Thus, alpha (4
)beta (1) activation determines a set point or threshold at which VCAM-1 ca
n regulate alpha (L)beta (2)-dependent as well as alpha (4)beta (1)-depende
nt cell migration. Changes in this set point may specify preferred anatomic
al sites of integrin-dependent leukocyte emigration from the bloodstream.